Palvella Therapeutics, Inc. (PVLA)
150.68
-3.64
(-2.36%)
USD |
NASDAQ |
Sep 18, 16:00
150.68
0.00 (0.00%)
After-Hours: 16:07
Palvella Therapeutics Price : 150.68 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 154.78 | 156.78 | 151.55 | 154.32 | 157921.0 |
| Sep 16, 2026 | 152.54 | 155.18 | 150.76 | 151.43 | 201973.0 |
| Sep 15, 2026 | 152.72 | 155.63 | 148.14 | 151.22 | 215632.0 |
| Sep 14, 2026 | 150.14 | 153.40 | 150.14 | 151.69 | 223049.0 |
| Sep 11, 2026 | 152.75 | 154.30 | 149.98 | 150.13 | 163366.0 |
| Sep 10, 2026 | 148.43 | 151.36 | 147.10 | 150.39 | 266083.0 |
| Sep 09, 2026 | 147.26 | 155.00 | 145.91 | 151.34 | 149392.0 |
| Sep 08, 2026 | 153.42 | 157.93 | 151.58 | 152.28 | 165031.0 |
| Sep 04, 2026 | 152.95 | 157.45 | 152.95 | 157.24 | 162268.0 |
| Sep 03, 2026 | 152.95 | 155.92 | 150.76 | 155.47 | 249669.0 |
| Sep 02, 2026 | 153.76 | 157.00 | 149.68 | 152.95 | 125223.0 |
| Sep 01, 2026 | 150.00 | 152.06 | 148.68 | 150.55 | 119939.0 |
| Aug 31, 2026 | 147.95 | 152.89 | 143.47 | 152.59 | 245780.0 |
| Aug 28, 2026 | 148.65 | 153.28 | 148.35 | 149.97 | 191992.0 |
| Aug 27, 2026 | 154.04 | 156.04 | 149.04 | 150.33 | 232752.0 |
| Aug 26, 2026 | 148.18 | 154.74 | 144.22 | 154.33 | 194445.0 |
| Aug 25, 2026 | 148.59 | 151.54 | 145.14 | 148.24 | 191989.0 |
| Aug 24, 2026 | 141.78 | 146.69 | 136.06 | 145.75 | 315523.0 |
| Aug 21, 2026 | 145.55 | 146.92 | 138.54 | 142.04 | 161873.0 |
| Aug 20, 2026 | 145.32 | 148.35 | 139.92 | 142.58 | 208991.0 |
| Aug 19, 2026 | 156.77 | 157.06 | 142.12 | 149.96 | 217206.0 |
| Aug 18, 2026 | 152.36 | 154.56 | 149.05 | 150.42 | 147985.0 |
| Aug 17, 2026 | 154.39 | 157.65 | 152.33 | 153.52 | 187027.0 |
| Aug 14, 2026 | 156.55 | 160.33 | 154.35 | 156.13 | 109816.0 |
| Aug 13, 2026 | 156.00 | 158.87 | 150.40 | 156.55 | 243209.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.855 |
| Amgen, Inc. | 385.64 |
| Anika Therapeutics, Inc. | 20.69 |
| BioCryst Pharmaceuticals, Inc. | 8.67 |
| Imunon, Inc. | 1.35 |
Price Related Metrics
| Price to Book Value | 10.00 |
| Earnings Yield | -3.21% |
| Market Cap | 2.169B |